Characterization of best optimized levobunolol hydrochloride occusert formulations with special reference to glaucoma treatment

Indian Journal of Pharmaceutical Education and Research

Volumn 45, Issue 4, 2011, Pages 326-332

  Pandey, Ashish ^a   Mali, Prashant Y ^b   Sachdeva, Dinesh ^c   Ramesh, Ravda ^d  

^a GURUKUL KANGRI UNIVERSITY   (India)

^b Adama University   (Ethiopia)

^c Rajasthan State Pharmacy Council   (India)

^d Dr H L Thimmegowda College of Pharmacy   (India)

Author keywords

Characterization; Glaucoma; Levobunolol HCL; Occusert

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE; LEVOBUNOLOL; METHYLCELLULOSE; POLYMER; POVIDONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG SAFETY; DRUG STABILITY; EYE IRRITATION; GLAUCOMA; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PHYSICAL CHEMISTRY; RABBIT; RELIABILITY;

EID: 83055170743     PISSN: 00195464     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Imam S, Bansal A, Bushetti SS, Singh A and Chopra H. Novel ocular dosage form in the treatment of glaucoma. The Pharma Res 2009; 01:72-81.
2. Saxena R, Prakash J, Mathur P and Gupta SK. Pharmacotherapy of Glaucoma. Indian J Pharmacol 2002; 34:71-85.
3. BETAGAN - Levobunolol hydrochloride solution, Allergan Inc. U.S.A (2005), Available from URL:http://www.dailymed.nlm.nih.govdailymeddrugInfo.cfmid=6973.
4. Pandey A, Mali PY, Sachdeva D, Patel DK and Ravda R. Development and optimization of levobunolol hydrochloride in-situ gel for glaucoma treatment. Int J Pharma Bio Archiv 2010; 1(2):134-139.
5. Manikandar VM, Narkilli SN, Prabaharan P and Karthikayini M. Formulation and evaluation of ciprofloxacin hydrochloride occuserts. The Eastern Pharmacist 1998; 101 (487):131.
6. Gupta A, Sharma SK, Ahuja M. In vitro and in vivo evaluation of gellan based ocular inserts of phenylephrine. Acta Pharma Sci 2000; 49:55-63.
7. Saisivam S, Muthumanikandar RV and Nagarajan M. Design and evaluation of ciprofloxacin HCl occuserts. Indian J Pharma Sci 1999; 61:34-38.
8. Manvi FV, Soppimath KS and Gadad AP. Development and evaluation of timolol maleate ocular inserts. Indian Drugs 1997; 34:264-268.
9. Sultana Y, Aquil M, Ali A. Ocular insert for controlled delivery of pefloxacin mesylate: preparation and evaluation. Acta Pharma Sci 2005; 55:305-314.
10. Ale A, Sharma SN. Fabrication of a through flow apparatus for in-vitro determination of drug from ophthalmic preparations. Indian Drugs 1991; 29:157-160.
11. The Indian Pharmacopoeia, Vol. II, Ministry of Health and Family Welfare, Govt. of India, Controller of Publications: New Delhi, 1996, A117-A123.
12. John H, Geoffrey W and Herbert OC. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Therap 1944; 82:377-390.
13. Sankar V, Chandrasekaran AK, Durga S, Geetha G, Ravichandran VA. Design and evaluation of diclofenac sodium ophthalmic inserts. Acta Pharma Sci 2006; 48:5-10.
14. Deoa J, Khopade MR, Jain NK. Development of liquid crystalline proliposomal gel for sustained ophthalmic drug delivery. Indian Drugs 1997; 34(5):252-257.
15. Sreenivas SA, Hiremanth SP and Godbole AM. Ofloxacin ocular inserts: Design, formulation and evaluation. Indian J Pharm Tech 2006; 5:159-162.